The easy availability of medication and delivery systems, prevailing incidences of type1 diabetes and the shifting focus towards self-management of diabetes can be credited for the market expansion.
The Global Insulin Delivery system market was valued at $10963 million in 2016 and is predicted to rise up to $24034 million by 2025, growing at an estimated CAGR of 9.11%.
Get this Research Report at www.reportsnreports.com/contacts/d…aspx?name=1205102
Becton, Dickinson, and Company operates across Canada, US, Latin America, the Middle East & Africa, Europe, and Asia Pacific. The company provides laboratory equipment and diagnostic products and devices for life science researchers, healthcare institutions, clinical laboratories, and the pharmaceutical industry.
Some of the other leading market players include Animas Corporation (Johnson and Johnson), Tandem Diabetes Care, Eli Lilly And Company, Biocon Limited, Insulet Corporation, Novo Nordisk A/S, Medtronic Plc, Sanofi, and Ypsomed Holding Ag.
The Global Insulin Delivery System Market is segmented on the basis of products and end users. The products are further divided into insulin pumps, insulin syringes, insulin pens, and insulin jet injectors.
Of these, Insulin pens are most popular in the market. The end-users for the market include hospitals and clinics, home care and others.
Hospitals are the leading end-users for the market since they utilize these delivery systems on a large scale and considerably engage with reimbursement authorities, government organizations and the suppliers for the same.
For More Detailsat www.reportsnreports.com/contacts/i…aspx?name=1205102
Geographically, the global Insulin delivery system market is segmented on the basis of five major regions including Asia-Pacific, Europe, North America, Latin America and the rest of the world. The Asia-Pacific region is predicted to be the fastest-growing region for the forecast period with India and China being its major contributor.
However, the North American market is anticipated to hold the biggest share by 2025, owing to the rising prevalence of type 1 diabetes and the growing obese and overweight population. The increasing government support is also contributing to propel the market ahead.
Direct Access at www.reportsnreports.com/purchase.aspx?name=1205102
Table of Contents:
1. Research Scope
- Research Methodology
- Executive Summary
- Market Dynamics
- Market By Components
- Market By Type
- Market By Application
- Market By End Users
- Key Analytics
- Geographical Analysis
- Company Profiles
List of Tables
List of Figures